María José
Larráyoz Ilundáin
Clínico Asociado
Hospital Virgen del Camino
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (4)
2020
-
Assessment of minimal residual disease by next generation sequencing in peripheral blood as a complementary tool for personalized transplant monitoring in myeloid neoplasms
Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-20
2015
-
Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations
British Journal of Haematology
2005
-
NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2
Cancer Genetics and Cytogenetics, Vol. 157, Núm. 2, pp. 151-156
2003
-
NUP98 is fused to Adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15)
Cancer Research, Vol. 63, Núm. 12, pp. 3079-3083